8-K: FOXO Technologies Secures $5 Million Equity Line with ClearThink Capital Partners

FOXO Technologies has entered into a Strata Purchase Agreement with ClearThink Capital Partners for up to $5 million in funding through the sale of its Class A common stock.

Summary

• FOXO Technologies has secured a $5 million equity line of credit with ClearThink Capital Partners.
• The agreement allows FOXO to sell up to $5 million of its Class A common stock to ClearThink.
• The purchase price for the shares will be the closing price on the purchase date.
• Purchases are subject to certain limits, including a minimum of $25,000 and a maximum of the lesser of $1,000,000 or 300% of the average daily trading value over the ten days preceding the request.
• Request notices must be at least 10 business days apart.
• ClearThink's ownership cannot exceed 9.99% of FOXO's outstanding common stock.
• FOXO is required to file a registration statement with the SEC within 60 days to cover the shares issued under the agreement.
• If FOXO seeks a similar equity line within 24 months, they must first negotiate with ClearThink.
• J.H. Darbie & Co. acted as a finder and will receive a 4% cash fee and warrants equal to 1% coverage of the amount raised.

Sentiment

Score: 6

Explanation: The agreement provides necessary funding but also introduces potential dilution and costs. It's a neutral to slightly positive development, typical for a company seeking capital.

Positives

• FOXO gains access to a flexible $5 million equity line of credit.
• The agreement provides a mechanism for raising capital as needed.
• The structure allows FOXO to sell shares at market prices.
• The agreement includes a first right of negotiation for ClearThink on future similar deals.

Negatives

• The agreement could lead to dilution of existing shareholders.
• The company is obligated to pay a 4% cash fee and issue warrants to the finder.
• The company is restricted from entering into similar agreements without first negotiating with ClearThink.

Risks

• The company's stock price could be negatively impacted by the issuance of new shares.
• There is a risk of dilution for existing shareholders.
• The company's ability to raise capital in the future could be limited by the terms of this agreement.
• The company is subject to certain restrictions on issuing shares that could impact its ability to raise capital.

Future Outlook

The company intends to use the net proceeds from the offering for any corporate purpose at its sole discretion. The company will also need to file a registration statement with the SEC within 60 days and may need to negotiate with ClearThink if it seeks a similar equity line within 24 months.

Industry Context

This type of agreement is common for companies seeking flexible access to capital, particularly in the biotech and technology sectors. It allows companies to raise funds without the immediate need for a large, traditional offering.

Comparison to Industry Standards

• Similar agreements are often seen with small to mid-cap companies seeking growth capital.
• The 9.99% ownership cap is a standard provision to avoid triggering shareholder approval requirements.
• The use of a finder and the associated fees and warrants are typical in these types of transactions.
• Comparable companies that have used similar financing structures include those in the biotech and tech industries that require flexible access to capital for research and development or expansion.

Stakeholder Impact

• Shareholders may experience dilution due to the issuance of new shares.
• The company gains access to capital, which could benefit its operations and growth.
• The company's financial position is strengthened by the potential influx of funds.
• The company's ability to execute its business plan may be enhanced.

Next Steps

• The company needs to file a registration statement with the SEC within 60 days.
• The company will need to satisfy the commencement conditions to begin selling shares to ClearThink.
• The company will need to manage the potential dilution of existing shareholders.
• The company will need to comply with the terms of the agreement, including the restrictions on future similar agreements.

Key Dates

Keywords

equity line, capital raise, common stock, Strata Purchase Agreement, ClearThink Capital Partners, registration rights, share dilution, funding, J.H. Darbie & Co.